On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...

The CHMP recommends approval of Bristol Myers' Opdivo plus Yervoy for the first-line treatment of hepatocellular carcinoma ...

Drawing on 35 years of experience in the development and production of high-temperature ceramic fibre, RATH is always looking ...

The FDA has granted Fast Track Designation to Adicet Bio’s ADI-001, an allogeneic gamma delta CAR T-cell therapy, for ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 5 undervalued ...

The sodium silicate market is driven by its versatile applications across industries such as detergents, construction, and water treatment, owing to its binding, adhesive, and coagulating properties.

EX937 utilizes a differentiated approach by inhibiting the FAAH enzyme, which increases the levels of Anandamide, an ...

Kura Oncology (KURA) stock slid 7% in post-market trading after the company issued an update on its drug ziftomenib.

Syndax Pharma (SNDX) stock rose after Kura Oncology (KURA) posted a mid-stage trial win for a leukemia drug is similar to ...

Metronomic chemotherapy (MC) is emerging as a groundbreaking treatment for pediatric neuroblastoma, offering a more accessible and manageable option for children with high-risk and relapsed/refractory ...

Kuro Oncology and partner Kyowa Kirin are on track for an NDA submission for ziftomenib in the second quarter of this year.